Related Experiment Video
Updated: Jun 3, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Molecular analysis of thyroid tumors
1Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA. nikiforovye@upmc.edu
Summary
Recent advances reveal key molecular alterations in thyroid cancer. These markers aid diagnosis, predict prognosis, and guide treatment, improving patient management and surgical decisions.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Numerous molecular alterations in thyroid cancer have been identified and characterized recently.
- These molecular markers hold potential for diagnosis, prognostication, and targeted therapy in thyroid cancer.
- Their diagnostic utility is especially crucial for thyroid fine-needle aspiration samples.
Purpose of the Study:
- To review significant molecular alterations in thyroid cancer.
- To focus on extensively characterized markers with clinical significance.
- To discuss markers being integrated into pathology practice.
Main Methods:
- Literature review of major molecular alterations in thyroid cancer.
- Focus on characterized markers with clinical relevance.
- Analysis of markers applicable to pathology practice.
Main Results:
- BRAF and other molecular markers aid in risk stratification for thyroid cancer.
- These markers can optimize surgical and postsurgical management strategies.
- Identified markers possess diagnostic utility, particularly in fine-needle aspiration samples.
Conclusions:
- Molecular alterations are pivotal in modern thyroid cancer management.
- Characterized markers enhance diagnostic accuracy and therapeutic targeting.
- Integration of molecular markers into pathology practice is transforming patient care.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...